Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company's Board of Directors

16.01.2024 - Regulatory News: The Board of Directors of GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (the 'Company'), a biopharma company focused on developing and commercializing innovative gene therapies for retinal ...

Related Keywords

France ,Laurence Rodriguez ,Gensight Biologics ,Sanofi Genzyme ,Bernard Gilly , ,Chief Executive Officer ,Rare Diseases ,Rare Blood Disorders ,Alain Sahel ,Sight Biologic ,Mitochondrial Targeting Sequence ,Leber Hereditary Optic Neuropathy ,Gensight Biologic ,Gensight Biologics Stock ,